Prosecution Insights
Last updated: April 19, 2026
Application No. 18/890,956

FORCEPS DEVICE

Non-Final OA §102§103
Filed
Sep 20, 2024
Examiner
DAVID, SHAUN L
Art Unit
3771
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Riverfield Inc.
OA Round
1 (Non-Final)
73%
Grant Probability
Favorable
1-2
OA Rounds
3y 8m
To Grant
92%
With Interview

Examiner Intelligence

Grants 73% — above average
73%
Career Allow Rate
405 granted / 557 resolved
+2.7% vs TC avg
Strong +19% interview lift
Without
With
+19.4%
Interview Lift
resolved cases with interview
Typical timeline
3y 8m
Avg Prosecution
58 currently pending
Career history
615
Total Applications
across all art units

Statute-Specific Performance

§101
2.1%
-37.9% vs TC avg
§103
33.9%
-6.1% vs TC avg
§102
28.2%
-11.8% vs TC avg
§112
26.2%
-13.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 557 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1, 4-6, 7, 10-12, 13, and 16-17 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by US 2006/0079884 A1 to Manzo et al. (hereinafter “Manzo”). Regarding claim 1, Manzo discloses (see abstract; Figs. 1-9C; and [0029]-[0060]) a forceps device (see Figs. 4-6C) comprising: a distal end part (Figs. 5A-B) including a treatment part (28) for treating an object; a columnar member (29, including 29B, see Fig. 5A/6B) connected to the distal end part (see [0038]); a pipe (23) connected to the columnar member on a side thereof opposite a side with which the distal end part is connected (see [0038]-[0041] and Figs. 5A-6C); a cover (38) mounted over the distal end part and the columnar member (see Figs. 5A-C and [0041]-[0042]); and an enlarged-diameter portion (stop shoulder 56) having a larger diameter than an end face, on a side closer to the pipe, of the cover that is mounted over the columnar member (see Figs. 5A-C and [0042]), wherein the enlarged-diameter portion is located at a position covering the end face (see Figs. 5B-C). Manzo further discloses (claim 4) wherein the enlarged-diameter portion is provided at the pipe (see Figs. 5A-C and [0042]); (claim 5) wherein a diameter of the enlarged-diameter portion on a columnar member side is smaller than an inner diameter of a trocar into which the forceps device is configured to be inserted (inserting into a trocar is an intended use recitation, however, if the forceps device is inserted into a trocar, the diameter of the enlarged-diameter portion would have to be smaller than the inner diameter of the trocar for the device to actually be inserted into the trocar); (claim 6) a wire (68) connected to the treatment part for causing the treatment part to operate (see [0048]), wherein the columnar member comprises a through-hole through which the wire extends (see Figs. 8A-9C). Regarding claim 7, Manzo discloses (see abstract; Figs. 1-9C; and [0029]-[0060]) a forceps device (see Figs. 4-6C) comprising: a distal end part (Figs. 5A-B) including a treatment part (28) for treating an object; a base cap (29, including 29B, see Fig. 5A/6B) connected proximally to the distal end part (see [0038]); a pipe (23) connected proximally to the base cap (see [0038]-[0041] and Figs. 5A-6C); a cover (38) that covers the distal end part and the base cap and has an end face at a proximal end of the base cap (see Figs. 5A-C and [0042]); and an enlarged-diameter portion (stop shoulder 56) having a diameter that is larger than a diameter of the end face of the cover (see Figs. 5A-C and [0042]). Manzo further discloses (claim 10) wherein the enlarged-diameter portion is provided at the pipe (see Figs. 5A-C and [0042]); (claim 11) wherein the diameter of the enlarged-diameter portion is smaller than an inner diameter of a trocar into which the forceps device is configured to be inserted (inserting into a trocar is an intended use recitation, however, if the forceps device is inserted into a trocar, the diameter of the enlarged-diameter portion would have to be smaller than the inner diameter of the trocar for the device to actually be inserted into the trocar); (claim 12) a wire (68) connected to the treatment part (see [0048]), wherein the base cap comprises a through-hole through which the wire extends (see Figs. 8A-9C). Regarding claim 13, Manzo discloses (see abstract; Figs. 1-9C; and [0029]-[0060]) a forceps device (see Figs. 4-6C) comprising: a distal end part (Figs. 5A-B) including a treatment part (28) for treating an object; a base cap (29, including 29B, see Fig. 5A/6B) connected proximally to the distal end part (see [0038]); a pipe (23) connected proximally to the base cap (see [0038]-[0041] and Figs. 5A-6C); a cover (38) that covers the distal end part and the base cap and has an end face at a proximal end of the base cap (see Figs. 5A-C and [0042]); and a hood (stop shoulder 56) having a diameter that is larger than a diameter of the end face of the cover (see Figs. 5A-C and [0042]). Manzo further discloses (claim 16) wherein the is mounted at the pipe (see Figs. 5A-C and [0042]); (claim 17) wherein the diameter of the hood is smaller than an inner diameter of a trocar into which the forceps device is configured to be inserted (inserting into a trocar is an intended use recitation, however, if the forceps device is inserted into a trocar, the diameter of the hood would have to be smaller than the inner diameter of the trocar for the device to actually be inserted into the trocar). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claim(s) 2-3, 8-9, and 14-15 is/are rejected under 35 U.S.C. 103 as being unpatentable over Manzo in view of US 2008/0300629 A1 to Surti (hereinafter “Surti”). Manzo fails to specifically disclose, with respect to claim 2, wherein the enlarged-diameter portion has a tapered shape in which a diameter of the enlarged-diameter portion decreases from an end adjacent to the columnar member toward an end adjacent to the pipe, although Mando does disclose with respect to claim 3 wherein a diameter of the enlarged-diameter portion at the end adjacent to the pipe is smaller than a diameter of the pipe (see Figs. 5A-C and [0042]). Manzo teaches that the enlarged-diameter portion is a stop shoulder (see [0042]). Surti discloses (see Figs. 3/6, [0021], [0024], [0030]) the known use in the field of surgery of a stop shoulder (40) comprising an enlarged-diameter portion having a tapered shape (48) in which a diameter of the enlarged diameter portion decreases (see Figs. 3/6) which acts to limit the further movement of a sleeve (24) by abutting the proximal end surface of the sleeve (see [0030]). It would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention, as a matter of combining prior art elements according to known method to yield predictable results (see KSR International Co. v. Teleflex Inc., 550 U.S. 398,82 USPQ2d 1385,1395- 97(2007)), to obtain the predictable result of a tapered stop shoulder instead of a straight stop shoulder, since Manzo teaches a straight stop shoulder which functions to abut the proximal end of cover 38 and prevent further proximal movement thereof (see [0042]), and Surti discloses a tapered stop shoulder which functions to abut the proximal end of the sleeve 24 to prevent further proximal movement thereof (see [0030]), and therefore it would have been predictable to one of ordinary skill in the art to use a tapered stop shoulder instead of a straight stop shoulder since they both provide the same predictable function of abutting a proximal end of a sleeve/cover to prevent further proximal movement thereof. Manzo fails to specifically disclose, with respect to claim 8, wherein the enlarged-diameter portion has a tapered shape in which the diameter of the enlarged-diameter portion decreases from an end of the enlarged-diameter portion that is adjacent to the base cap toward an end of the enlarged-diameter portion that is adjacent to the pipe, although Mando does disclose with respect to claim 9 wherein the diameter of the enlarged-diameter portion at the end of the enlarged-diameter portion that is adjacent to the pipe is smaller than a diameter of the pipe (see Figs. 5A-C and [0042]). Manzo teaches that the enlarged-diameter portion is a stop shoulder (see [0042]). Surti discloses (see Figs. 3/6, [0021], [0024], [0030]) the known use in the field of surgery of a stop shoulder (40) comprising an enlarged-diameter portion having a tapered shape (48) in which a diameter of the enlarged diameter portion decreases (see Figs. 3/6) which acts to limit the further movement of a sleeve (24) by abutting the proximal end surface of the sleeve (see [0030]). It would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention, as a matter of combining prior art elements according to known method to yield predictable results (see KSR International Co. v. Teleflex Inc., 550 U.S. 398,82 USPQ2d 1385,1395- 97(2007)), to obtain the predictable result of a tapered stop shoulder instead of a straight stop shoulder, since Manzo teaches a straight stop shoulder which functions to abut the proximal end of cover 38 and prevent further proximal movement thereof (see [0042]), and Surti discloses a tapered stop shoulder which functions to abut the proximal end of the sleeve 24 to prevent further proximal movement thereof (see [0030]), and therefore it would have been predictable to one of ordinary skill in the art to use a tapered stop shoulder instead of a straight stop shoulder since they both provide the same predictable function of abutting a proximal end of a sleeve/cover to prevent further proximal movement thereof. Manzo fails to specifically disclose, with respect to claim 14, wherein the hood has a tapered shape in which a diameter of the hood decreases from a first end of the hood that is adjacent to the base cap toward a second end of the hood that is adjacent to the pipe, although Mando does disclose with respect to claim 15 wherein a diameter of hood at the second end is smaller than a diameter of the pipe (see Figs. 5A-C and [0042]). Manzo teaches that the enlarged-diameter portion is a stop shoulder (see [0042]). Surti discloses (see Figs. 3/6, [0021], [0024], [0030]) the known use in the field of surgery of a stop shoulder (40) comprising an enlarged-diameter portion having a tapered shape (48) in which a diameter of the enlarged diameter portion decreases (see Figs. 3/6) which acts to limit the further movement of a sleeve (24) by abutting the proximal end surface of the sleeve (see [0030]). It would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention, as a matter of combining prior art elements according to known method to yield predictable results (see KSR International Co. v. Teleflex Inc., 550 U.S. 398,82 USPQ2d 1385,1395- 97(2007)), to obtain the predictable result of a tapered stop shoulder instead of a straight stop shoulder, since Manzo teaches a straight stop shoulder which functions to abut the proximal end of cover 38 and prevent further proximal movement thereof (see [0042]), and Surti discloses a tapered stop shoulder which functions to abut the proximal end of the sleeve 24 to prevent further proximal movement thereof (see [0030]), and therefore it would have been predictable to one of ordinary skill in the art to use a tapered stop shoulder instead of a straight stop shoulder since they both provide the same predictable function of abutting a proximal end of a sleeve/cover to prevent further proximal movement thereof. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to SHAUN L DAVID whose telephone number is (571)270-5263. The examiner can normally be reached M-F 10AM-6:30PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Darwin Erezo can be reached at 571-272-4695. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /SHAUN L DAVID/Primary Examiner, Art Unit 3771
Read full office action

Prosecution Timeline

Sep 20, 2024
Application Filed
Jan 22, 2026
Non-Final Rejection — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12582396
METHODS AND DEVICES FOR MANIPULATING AND FASTENING TISSUE
2y 5m to grant Granted Mar 24, 2026
Patent 12582407
DEVICES AND METHODS FOR APPLYING A HEMOSTATIC CLIP ASSEMBLY
2y 5m to grant Granted Mar 24, 2026
Patent 12569242
DEVICE AND METHOD FOR FIXATING A SUTURE ANCHOR IN HARD TISSUE
2y 5m to grant Granted Mar 10, 2026
Patent 12564402
REVERSE ANASTOMOSIS CLOSURE CLIP
2y 5m to grant Granted Mar 03, 2026
Patent 12564398
IMPLANT DEPLOYMENT DEVICE
2y 5m to grant Granted Mar 03, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
73%
Grant Probability
92%
With Interview (+19.4%)
3y 8m
Median Time to Grant
Low
PTA Risk
Based on 557 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month